Durataf 25mg Tablet
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Tenofovir Alafenamide (25mg)
Overview Durataf 25mg Tablet
Tenofovir 25mg tablets combat HIV and chronic hepatitis B (HBV) infections by hindering viral replication within human cells, thus curbing viral production and facilitating infection resolution. Dosage and treatment duration should strictly adhere to your physician's instructions; complete the prescribed course regardless of symptom improvement. Administer the medication with food to optimize absorption. Continue treatment until medically advised to discontinue. Common side effects include headache, nausea, diarrhea, arthralgia, abdominal discomfort, and dyspepsia. Persistent side effects warrant medical attention; while generally mild, report any bothersome or persistent symptoms. Rarely, skin reactions or liver injury may occur, necessitating close monitoring, especially early in treatment. Prior to commencing treatment, disclose any pre-existing skin conditions, liver or kidney ailments. Regular blood tests to assess blood cell counts and liver function are typically required. Alcohol consumption should be avoided due to increased liver damage risk. Pregnant or lactating individuals should seek medical counsel before use. HIV-positive individuals must practice safe sex and avoid sharing personal items like razors or toothbrushes to prevent transmission. Discuss safe sex practices, such as condom use, with your doctor.
Primary Ingredients of Durataf 25mg Tablet
No text provided to rephrase.
Uses of Durataf 25mg Tablet
Managing persistent Hepatitis B virus (HBV) infection
Major Benefits of Durataf 25mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Durataf 25mg Tablet should be administered with a meal.
Common Side effects of Durataf 25mg Tablet:
- Headache
- Diarrhea
- Nausea
- Fatigue
- Abdominal pain
- Cough
- Back pain
- Indigestion
- Joint pain
How to use Durataf 25mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 25mg Durataf Tablet should be taken with a meal.
How Durataf 25mg Tablet works:
Each 25mg Durataf tablet delivers antiviral action, hindering viral replication within human cells. This effectively halts further virus production, thereby resolving the infection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Durataf 25mg Tablet may be unsafe; physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
Use of Durataf 25mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nonetheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Using Durataf 25mg tablets while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingUNSAFE
Taking a Durataf 25mg Tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Durataf 25mg Tablets cautiously, as dosage modification may be necessary. A physician's consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Durataf 25mg Tablets in patients with liver impairment is likely safe. Existing evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
What if you forget to take Durataf 25mg Tablet :
Should you forget a Durataf 25mg Tablet dose, take it immediately. If your next dose is nearly due, however, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Durataf 25mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Base analog |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Reverse transcriptase inhibitors (RTIs) based on nucleosides or nucleotides |






